and/or

907 Blog posts found

Q&A

Each Patient Is a Unique Human Being, Not a Disease or a Group of Symptoms

MSK critical care physician Louis Voigt is a firm believer in a holistic approach to the practice of medicine, as well as to his patients and their loved ones.

Pictured: Louis Voigt

Feature

Spotlight on Pathology: A Key Component of Cancer Care

The most effective cancer treatment starts with an accurate diagnosis. Pathologist Meera Hameed explains the pathologist’s crucial contributions.

Pathology assistant Annabel Canhao analyses tissue from a biopsy.

In the Lab

Investigators Use Stem Cells to Study Rare Pediatric Brain Tumors

Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture.

Pictured: Viviane Tabar

In the Clinic

Restoring Limb Length Following Bone Cancer Surgery

Memorial Sloan Kettering has taken the lead in applying a limb-lengthening technique in people with bone cancer to restore long gaps in bone after removal of a tumor.

Limb lengthening

Q&A

At Work: Interventional Radiologist William Alago

Interventional radiologist William Alago discusses minimally invasive procedures, advances in imaging techniques, and the future of his field.

Pictured: William Alago

In the Lab

New Findings Clarify How Immunotherapy Works — and Why, In Some People, It Doesn’t

In people with melanoma who respond to the drug ipilimumab, certain mutations make tumors more visible to the immune system.

Pictured: Jedd Wolchok, Alexandra Snyder Charen and Timothy Chan

Finding

Immunotherapy Shows Promise for Treating Solid Tumors in the Chest

A study in mouse models suggests how modified T cells may be used to treat tumors in the area just outside the lungs.

Michel Sadelain and Prasad Adusumilli

Giving

A Not-So-Stiff Upper Lip

Mustaches for Kids raises funds for Memorial Sloan Kettering’s pediatric patients in a most hairy way.

Billy Kupferman of Mustaches for Kids and Eve H.

Finding

Study Reveals How Some Breast Cancers Become Resistant to Targeted Drugs

A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.

(From left) MSK investigators Michael Berger, José Baselga, and Maurizio Scaltriti, and graduate student Pau Castel.

In the Lab

Beyond the Usual Suspects: Study of Noncoding DNA Reveals New Mutations Linked to Cancer

In a study of patient tumor samples, researchers have found common mutations in parts of the genome that control gene regulation.

Pictured: William Lee, Chris Sander & Nils Weinhold